[Epilepsy and monoamines in the brain].
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004336:Drug Antagonism; D004827:Epilepsy / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007490:Iproniazid / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D010672:Phenytoin / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism
D001679:Biogenic Amines; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010406:Penicillins; D012701:Serotonin; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D007490:Iproniazid; D004298:Dopamine